Sprint Bioscience AB (publ)

OM:SPRINT Stock Report

Market Cap: SEK 108.2m

Sprint Bioscience Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Johan Emilsson

Chief executive officer

SEK 1.7m

Total compensation

CEO salary percentage25.0%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure3.4yrs
Board average tenure5yrs

Recent management updates

Recent updates

Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Jun 12
Estimating The Fair Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Feb 19
A Look At The Intrinsic Value Of Sprint Bioscience AB (publ) (STO:SPRINT)

Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

Nov 19
Is Sprint Bioscience (STO:SPRINT) In A Good Position To Deliver On Growth Plans?

CEO Compensation Analysis

How has Johan Emilsson's remuneration changed compared to Sprint Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 19m

Jun 30 2024n/an/a

SEK 15m

Mar 31 2024n/an/a

SEK 9m

Dec 31 2023SEK 2mSEK 420k

-SEK 438k

Compensation vs Market: Johan's total compensation ($USD151.87K) is below average for companies of similar size in the Swedish market ($USD231.15K).

Compensation vs Earnings: Insufficient data to compare Johan's compensation with company performance.


CEO

Johan Emilsson (40 yo)

1.3yrs

Tenure

SEK 1,680,000

Compensation

Mr. Johan Emilsson is Chief Executive Officer of Sprint Bioscience AB (publ) since October 01, 2023. He has broad experience in business development within the pharmaceutical industry and most recently fro...


Leadership Team

NamePositionTenureCompensationOwnership
Johan Emilsson
Chief Executive Officer1.3yrsSEK 1.68mno data
Pär Nordlund
Founderno dataSEK 25.00k0.91%
SEK 989.0k
Martin Andersson
Co-Founder & Chief Scientific Officer16yrsno datano data
Kenth Hallberg
Founder & Director of Structural Chemistryno datano datano data
Mathias Skalmstad
Chief Financial Officer3.4yrsno data0.10%
SEK 111.6k
Anne-Marie Wenthzel
Chief Business Officerno datano datano data

3.4yrs

Average Tenure

53yo

Average Age

Experienced Management: SPRINT's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Svein Mathisen
Independent Director5yrsSEK 150.00kno data
Bjorn Sjostrand
Independent Chairman of the Board4yrsSEK 300.00k1.26%
SEK 1.4m
Lewis Cantley
Member of Scientific Advisory Boardno datano datano data
Rune Nordlander
Director15yrsSEK 150.00kno data
Fredrik Lehmann
Independent Director5.7yrsSEK 150.00k0.072%
SEK 77.5k
Robert Devita
Member of Scientific Advisory Boardno datano datano data
Gunilla Enblad
Member of Scientific Advisory Boardno datano datano data
Karen From
Independent Director1.7yrsSEK 88.00kno data

5.0yrs

Average Tenure

61.5yo

Average Age

Experienced Board: SPRINT's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 20:48
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sprint Bioscience AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siri LadowDanske Bank
Christian BinderRedeye
Johan UnnerusRedeye